Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial peptide

Diabetes

Volumn 62, Issue 6, 2013, Pages 2036-2047

  Patrick, Christopher ^a,b   Wang, Gen Sheng ^a   Lefebvre, David E ^a,b,g   Crookshank, Jennifer A ^a   Sonier, Brigitte ^a   Eberhard, Chandra ^a,b   Mojibian, Majid ^a,b,h   Kennedy, Christopher R ^a,b,c   Brooks, Stephen P J ^d   Kalmokoff, Martin L ^e   Maglio, Mariantonia ^c   Troncone, Riccardo ^c   Poussier, Philippe ^f   Scott, Fraser W ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d HEALTH CANADA   (Canada)

^e Agriculture and Agri Food Canada Kentville   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g TOXICOLOGY RESEARCH DIVISION   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD163 ANTIGEN; CD8ALPHA ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 4; MESSENGER RNA; RNA 16S; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CEREAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FECES MICROFLORA; GERMFREE ANIMAL; HUMAN; IMMUNOCOMPETENT CELL; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MACROPHAGE; MALE; MICROBIAL COMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ANIMALS; CATHELICIDINS; CEREALS; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GASTROINTESTINAL TRACT; HUMANS; IMMUNOHISTOCHEMISTRY; JEJUNUM; MALE; RATS; RATS, INBRED BB; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84878226934     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1243     Document Type: Article

References (53)

1. Greenbaum C. Perspective: rethink the immune connection. Nature 2012;485:S9
2. Lefebvre DE, Powell KL, Strom A, Scott FW. Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu Rev Nutr 2006;26:175-202
3. Greenbaum CJ, Schatz DA, Haller MJ, Sanda S. Through the fog: recent clinical trials to preserve b-cell function in type 1 diabetes. Diabetes 2012;61:1323-1330
4. Maurano F, Mazzarella G, Luongo D, et al. Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat. Diabetologia 2005;48:931-937 (Pubitemid 40767987)
5. Watts T, Berti I, Sapone A, et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabeticprone rats. Proc Natl Acad Sci U S A 2005;102:2916-2921 (Pubitemid 40299891)
6. Graham S, Courtois P, Malaisse WJ, Rozing J, Scott FW, Mowat AM. Enteropathy precedes type 1 diabetes in the BB rat. Gut 2004;53:1437-1444 (Pubitemid 39265262)
7. Chakir H, Lefebvre DE, Wang H, Caraher E, Scott FW. Wheat protein-induced proinflammatory T helper 1 bias in mesenteric lymph nodes of young diabetes-prone rats. Diabetologia 2005;48:1576-1584 (Pubitemid 41175511)
8. Mojibian M, Chakir H, Lefebvre DE, et al. Diabetes-specific HLA-DR-restricted proin flammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes 2009;58:1789-1796
9. Turley SJ, Lee JW, Dutton-Swain N, Mathis D, Benoist C. Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci U S A 2005;102:17729-17733 (Pubitemid 41803565)
10. Muegge BD, Kuczynski J, Knights D, et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011;332:970-974
11. Beales PE, Elliott RB, Flohé S, et al. A multi-centre, blinded international trial of the effect of A(1) and A(2) beta-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes. Diabetologia 2002;45:1240-1246
12. Crookshank JA, Patrick C, Wang GS, Scott FW. Dietary protection from type 1 diabetes development associated with increased Foxp3+ cells in the gut immune system of the LEW.1AR1/Ztm-iddm rat (Abstract). Diabetes 2010;59:A89
13. Knip M, Virtanen SM, Seppä K, et al Finnish TRIGR Study Group. Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med 2010;363:1900-1908
14. Sildorf SM, Fredheim S, Svensson J, Buschard K. Remission without insulin therapy on gluten-free diet in a 6-year old boy with type 1 diabetes mellitus. BMJ Case Rep. 21 June 2012 [Epub ahead of print]
15. Scott FW, Rowsell P, Wang GS, Burghardt K, Kolb H, Flohé S. Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes. Diabetes 2002;51:73-78 (Pubitemid 34517982)
16. Wen L, Ley RE, Volchkov PY, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008;455:1109-1113
17. Wang GS, Kauri LM, Patrick C, Bareggi M, Rosenberg L, Scott FW. Enhanced islet expansion by beta-cell proliferation in young diabetes-prone rats fed a protective diet. J Cell Physiol 2010;224:501-508
18. Snell-Bergeon JK, Smith J, Dong F, et al. Early childhood infections and the risk of islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetes Care 2012;35:2553-2558
19. Wallis RH, Wang K, Marandi L, et al. Type 1 diabetes in the BB rat: a polygenic disease. Diabetes 2009;58:1007-1017
20. Auricchio R, Paparo F, Maglio M, et al. In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes 2004;53:1680-1683 (Pubitemid 38857024)
21. Roncador G, Brown PJ, Maestre L, et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 2005;35:1681-1691 (Pubitemid 40862316)
22. Sonier B, Patrick C, Ajjikuttira P, Scott FW. Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity. Int Rev Immunol 2009;28:414-445
23. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 2011;11:750-761
24. Blumberg H, Dinh H, Trueblood ES, et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 2007;204:2603-2614 (Pubitemid 350044786)
25. Johnston A, Xing X, Guzman AM, et al. IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol 2011;186:2613-2622
26. Nijnik A, Pistolic J, Wyatt A, Tam S, Hancock RE. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs. J Immunol 2009;183:5788-5798
27. Cardwell CR, Carson DJ, Patterson CC. No association between routinely recorded infections in early life and subsequent risk of childhood-onset type 1 diabetes: a matched case-control study using the UK General Practice Research Database. Diabet Med 2008;25:261 -267
28. Hviid A, Svanström H. Antibiotic use and type 1 diabetes in childhood. Am J Epidemiol 2009;169:1079-1084
29. Rossini AA, Williams RM, Mordes JP, Appel MC, Like AA. Spontaneous diabetes in the gnotobiotic BB/W rat. Diabetes 1979;28:1031-1032 (Pubitemid 10198198)
30. Alam C, Bittoun E, Bhagwat D, et al. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia 2011;54:1398-1406
31. Brugman S, Klatter FA, Visser JT, et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 2006;49:2105-2108 (Pubitemid 44168478)
32. Roesch LF, Lorca GL, Casella G, et al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J 2009;3:536-548
33. Visser JT, Bos NA, Harthoorn LF, et al. Potential mechanisms explaining why hydrolyzed casein-based diets outclass single amino acid-based diets in the prevention of autoimmune diabetes in diabetes-prone BB rats. Diabetes Metab Res Rev 2012;28:505-513
34. Valladares R, Sankar D, Li N, et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS ONE 2010;5:e10507
35. Meresse B, Malamut G, Cerf-Bensussan N. Celiac disease: an immunological jigsaw. Immunity 2012;36:907-919
36. Bobbala D, Chen XL, Leblanc C, et al. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse. Diabetologia 2012;55:3010-3020
37. Scott FW, Cloutier HE, Kleemann R, et al. Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells. Diabetes 1997;46:589-598 (Pubitemid 27143374)
38. Salmond RJ, Filby A, Qureshi I, Caserta S, Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev 2009;228:9-22
39. Lau K, Benitez P, Ardissone A, et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol 2011;186:3538-3546
40. van den Brandt J, Fischer HJ, Walter L, Hünig T, Klöting I, Reichardt HM. Type 1 diabetes in BioBreeding rats is critically linked to an imbalance between Th17 and regulatory T cells and an altered TCR repertoire. J Immunol 2010;185:2285-2294
41. Sakaguchi S, Ono M, Setoguchi R, et al. Foxp31 CD25 1 CD41 natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006;212:8-27 (Pubitemid 44116697)
42. Ejsing-Duun M, Josephsen J, Aasted B, Buschard K, Hansen AK. Dietary gluten reduces the number of intestinal regulatory T cells in mice. Scand J Immunol 2008;67:553-559 (Pubitemid 351677413)
43. Schenk M, Mueller C. Adaptations of intestinal macrophages to an antigenrich environment. Semin Immunol 2007;19:84-93 (Pubitemid 46810284)
44. Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology 2005;210:153-160 (Pubitemid 41025156)
45. Buechler C, Ritter M, Orsó E, Langmann T, Klucken J, Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 2000;67:97-103 (Pubitemid 30046823)
46. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A 2007;104:19446-19451
47. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008;60:79-127 (Pubitemid 351439218)
48. Parsa R, Andresen P, Gillett A, et al. Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes 2012;61:2881-2892
49. Nijnik A, Hancock RE. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol 2009;16:41-47
50. Ahluwalia A, Tarnawski AS. Cathelicidin gene therapy: a new therapeutic option in ulcerative colitis and beyond? Gene Ther 2013;20:119-120
51. Schauber J, Rieger D, Weiler F, et al. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2006;18:615-621 (Pubitemid 43804644)
52. Koon HW, Shih DQ, Chen J, et al. Cathelicidin signaling via the Toll-like receptor protects against colitis in mice. Gastroenterology 2011;141:1852- 1863, e1-e3
53. Tai EK, Wu WK, Wong HP, Lam EK, Yu L, Cho CH. A new role for cathelicidin in ulcerative colitis in mice. Exp Biol Med (Maywood) 2007;232:799-808 (Pubitemid 46827822)